Manufacturer record

Tulbros Formulations: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

4 batches manufactured by Tulbros Formulations (Uttarakhand) were declared Not of Standard Quality between September 2023 and November 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

4 records linked to Tulbros Formulations in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
4Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Sep 2023 to Nov 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

4
NSQ batches since 2023
4
Products affected
Dissolution
Most common failure
Nov 2025
Latest alert

Flagged batches per year

2023 · 12024 · 12025 · 2

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Milk of Magnesia, Liquid Paraffin & Sodium Picosulphate Suspension LXFPL606Mfg 2024-12 · Exp 2026-11 Description onlyDescription RDTL, Hubli, KarnatakaState lab Nov 2025
Seram DP SRDPT602Mfg 2024-11 · Exp 2026-10 The sample fails in the Test for Description of Tablets.Description MDTL Kathua,Jammu and KashmirState lab Oct 2025
CUCID-DM CDMC501Mfg 2023-05 · Exp 2025-04 THE SAMPLE DOES NOT COMPLY WITH IP REQUIREMENTS FOR DISSOLUTION TEST FOR OMEPRAZOLE IN ACID STAGE.Dissolution State Lab MaharashtraState lab Jun 2024
Montelukast & Levocetirizine Dihydrochloride Tablets I.P. (Lexzin-MK) LXMKT415Mfg 2023-02 · Exp 2025-01 Dissolution of MontalukastDissolution RDTL GuwahatiState lab Sep 2023

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.